Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000861177-23-000003
Filing Date
2023-02-13
Accepted
2023-02-13 10:52:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 PRELUDE_4Q2022_initial.txt SC 13G 8778
  Complete submission text file 0000861177-23-000003.txt   10597
Mailing Address ONE NORTH WACKER DRIVE CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE CHICAGO IL 60606 60606
UBS ASSET MANAGEMENT AMERICAS INC (Filed by) CIK: 0000861177 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Subject) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91717 | Film No.: 23615601
SIC: 2834 Pharmaceutical Preparations